Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety (Q34123368)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q54889429)
(P304) 919-930
(P407) (Q1860)
(P433) 4
(P478) 160
(P577) Tuesday, June 1, 2010
(P1433) (Q919631)
(P1476) "Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety" (language: en)
(P2093) C F Samer
Y Daali
M Wagner
G Hopfgartner
C B Eap
M C Rebsamen
M F Rossier
P Dayer
J A Desmeules
(P2860) (Q34979384)
(Q36994597)
(Q34522442)
(Q36357149)
(Q30993980)
(Q28300589)
(Q24319114)
(Q34274685)
(Q35057574)
(Q40703660)
(Q32039155)
(Q34450876)
(Q42554140)
(Q34363744)
(Q40294192)
(Q39531128)
(Q49160823)
(Q55050002)
(Q40223624)
(Q33756221)
(Q51549346)
(Q46861629)
(Q44870123)
(Q51995930)
(Q46330720)
(Q51483465)
(Q42170449)
(Q41811494)
(Q40906484)
(Q46508948)
(Q46724585)
(Q46031110)
(Q46090850)
(Q42244353)
(Q44333770)
(Q48411282)
(Q51809173)
(Q44904151)
(Q44550810)
(Q44337294)
(Q53920754)
(Q57987273)
(Q83297524)
(Q58812789)
(Q95816014)
(Q88775627)
(Q70866997)
(Q73224841)
other details